A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects
Public ClinicalTrials.gov record NCT02486406. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Ombitasvir (OBV), Paritaprevir (PTV), Ritonavir (RTV) With or Without Dasabuvir (DSV) and With or Without Ribavirin (RBV) in Pediatric Subjects With Genotype 1 or 4 Chronic Hepatitis C Virus (HCV) Infection (ZIRCON)
Study identification
- NCT ID
- NCT02486406
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
- Ombitasvir/paritaprevir/ritonavir Drug
- Dasabuvir Drug
- Ribavirin Drug
- Ombitasvir mini tablet Drug
- Paritaprevir mini tablet Drug
- Ritonavir mini tablet Drug
- Dasabuvir mini tablet Drug
- Ribavirin solution Drug
Drug
Eligibility (public fields only)
- Age range
- 3 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 27, 2015
- Primary completion
- Nov 18, 2020
- Completion
- Nov 18, 2020
- Last update posted
- Oct 4, 2021
2015 – 2020
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSF Benioff Childrens Hosp /ID# 136774 | San Francisco | California | 94158 | — |
| Children's Hospital Colorado /ID# 137017 | Aurora | Colorado | 80045 | — |
| University of Florida - Archer /ID# 136830 | Gainesville | Florida | 32610 | — |
| Advent Health /ID# 167663 | Orlando | Florida | 32803 | — |
| Indiana University /ID# 137015 | Indianapolis | Indiana | 46202 | — |
| Boston Childrens Hospital /ID# 137174 | Boston | Massachusetts | 02115 | — |
| Boston Medical Center /ID# 136831 | Boston | Massachusetts | 02118 | — |
| Columbia Univ Medical Center /ID# 136431 | New York | New York | 10032-3725 | — |
| Children's Hospital of Philadelphia /ID# 137018 | Philadelphia | Pennsylvania | 19104 | — |
| Baylor College of Medicine /ID# 136590 | Houston | Texas | 77030-3411 | — |
| Seattle Children's Hospital /ID# 137019 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02486406, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 4, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02486406 live on ClinicalTrials.gov.